Article

Review: Some Nonpharmacologic Treatment Effective in Pediatric GI Disorders

Author(s):

Nonpharmacologic treatments like hypnotherapy were reported effective in pediatric abdominal pain-related functional gastrointestinal disorders (AP-FGIDs).

Nonpharmacologic treatments like hypnotherapy were reported effective in pediatric abdominal pain-related functional gastrointestinal disorders (AP-FGIDs).

A review published online in Pediatrics observed vast improvement of abdominal pain post hypnotherapy versus standard care/wait list approaches and after cognitive behavioral therapy versus control/wait list approaches. They found that at the 6-month follow-up, written self-disclosure improved pain frequency.

Juliette M.T.M. Rutten, MD, from Emma's Children's Hospital in Amsterdam, and her research colleagues conducted a systematic review of the literature relating to nonpharmacologic interventions for pediatric AP-FGIDs. Data were included from 24 randomized controlled trials that included 1,390 children between the ages of 3-18 years.

Researchers noted that significantly more treatment responders had with Lactobacillus rhamnosus GG (LGG) and VSL#3 compared with placebo (LGG relative risk, 1.31; VSL#3 P < 0.05). Irritable bowel syndrome (IBS) symptom frequency was significantly improved with guar gum, however, there was no concrete effect indicated for any other fiber supplements or even a lactose-free diet.

When compared with a wait-list approach, yoga was found to not be linked to a substantial decrease in functional disability. Furthermore, no serious side effects were reported nor were there any indications of high levels of evidence quality.

"Although high-quality studies are lacking, some evidence shows efficacy of hypnotherapy, cognitive behavioral therapy, and probiotics (LGG and VSL#3) in pediatric AP-FGIDs," the authors concluded.

Related Videos
Christine Frissora, MD | Credit: Weill Cornell
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Age, Race, Ethnicity Disparities Hinder Celiac Disease Screening, with Debra Silberg, MD, PhD
Lauren Collen, MD: Advanced Combination Therapy May Be Effective Option for Pediatric Refractory IBD
© 2024 MJH Life Sciences

All rights reserved.